Chemoinformaics analysis of TRANS-ACONITIC-ACID
| Molecular Weight | 174.108 | nRot | 4 |
| Heavy Atom Molecular Weight | 168.06 | nRig | 4 |
| Exact Molecular Weight | 174.016 | nRing | 0 |
| Solubility: LogS | -0.291 | nHRing | 0 |
| Solubility: LogP | -0.296 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 18.8328 |
| nHD | 3 | BPOL | 8.62324 |
| QED | 0.498 |
| Synth | 2.613 |
| Natural Product Likeliness | 1.564 |
| NR-PPAR-gamma | 0.043 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.913 |
| CACO-2 | -6.025 |
| MDCK | 0.000141336 |
| BBB | 0.037 |
| PPB | 0.294323 |
| VDSS | 0.397 |
| FU | 0.414039 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.021 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.03 |
| CYP2c9-inh | 0.21 |
| CYP2c9-sub | 0.188 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.003 |
| CL | 1.675 |
| T12 | 0.941 |
| hERG | 0.003 |
| Ames | 0.034 |
| ROA | 0.035 |
| SkinSen | 0.93 |
| Carcinogencity | 0.019 |
| EI | 0.989 |
| Respiratory | 0.168 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.857582 |